NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia Status COMPLETED Phase PHASE2
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness Status TERMINATED Phase PHASE4
NCT00065273 Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay Status COMPLETED Phase PHASE3
NCT00051298 Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia Status COMPLETED Phase PHASE3
NCT00050206 Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder Status COMPLETED Phase PHASE4
NCT00036088 Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia Status COMPLETED Phase PHASE4
NCT00035321 The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression Status COMPLETED Phase PHASE3
NCT00034801 Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00034580 Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder Status COMPLETED Phase PHASE4
NCT00007774 To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia Status COMPLETED Phase PHASE4
NCT00001656 Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders Status COMPLETED Phase PHASE4